Home

  • Home
    • » e-Newsletters

New lung-cancer screening in development

Respiratory Care Weekly, September 13, 2006

Lung cancer screenings and testing can take a lot of appointments and lab work, making it prohibitive to check out large volumes of smokers for the disease and perhaps catch some cases early enough to improve survival. A new blood test may help make screenings more simple in the future, according to reports released at the first meeting on Molecular Diagnostics in Cancer Therapeutic Development. The blood test measures a protein called tNOX, which is a member of a family of proteins that are involved in cell growth.

"Our findings would  indicate whether additional testing would be required," said D. James Morre, PhD, distinguished professor of medicinal chemistry, who presented research. "We could screen very large smoker populations and eliminate perhaps 90% of them (for further testing), while encouraging the other 10 percent to go on to the next stage of testing."

Most Popular